Rony,I agree with you re PRR relying on its owns results for a...

Rony,

I agree with you re PRR relying on its owns results for a run on the SP.

I do however think that something is only just around the corner.

I base this on;

1. DNDN having just gained FDA approval only days before the start of the Bio Conference in the US will have them as stars of the show. This conference is for networking purposes.

2. PRR attending the same conference, having similar technology but at a huge discount to other available companies in the same field.

3. PRR recently gaining approval for an issue of unlisted options to National Security Corporation in the US who, amongst other things, are corporate advisors specialising in initial public offerings.

4. PRR's recent appointment of a new non-executive director who's experience lies in corporate advisory and has had directorships in start-ups now listed on the ASX.

It is an easy thing to join the dots for or against a company depending on where your interest lies.

For me, the four points I have raised above suggest that something very positive for Prima could be just around the corner that isnt directly linked to the advancement of the trialling of CVac.

I hope I am right, I may not be, but I am willing to let my investment ride on it.

PM